Partial
Mostly Aligned
Patient Risk:
Low
Summary
Two of four claims align with the provided label information (10 mL vial; Depo-Testosterone as a brand-name product). Two claims are not supported by the label (1 mL vial and generic version). The available label section 11 DESCRIPTION in the prompt describes AndroGel topical testosterone, which does not pertain to injectable testosterone cypionate, indicating misalignment between claims and label content.
Category Scores
Accurate Statements
10 mL vial of testosterone cypionate injection.
present in label (section 16 HOW SUPPLIED)
Depo-Testosterone is a brand-name product of testosterone cypionate.
present in label (section 11 DESCRIPTION)
Unsupported Statements
1 mL vial (typically 200 mg/mL) of testosterone cypionate injection.
absent from label (section 16 HOW SUPPLIED)
A generic version of testosterone cypionate is available.
absent from label (section 16 HOW SUPPLIED)
Contradictions
Important Omissions
The label sections provided do not contain injectable testosterone cypionate specifics (e.g., 1 mL vial details or generic status) and one cited description pertains to a topical product (AndroGel), indicating misalignment and incomplete injection-specific labeling.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Assessment limited to claim-label alignment; no safety-critical statements are present.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Suggested Improvement
Ensure AI-generated claims align with the correct label sections for injectable testosterone cypionate (e.g., dosage forms, vial sizes, brand/generic status) and avoid referencing topical description sections when discussing injectable products.